Page 492 - O_Desenvolvimento_do_Autismo
P. 492
BROWN, A. e SUSSER, E. “In utero infection and adult schizophrenia”.
Mental Retardation and Developmental Disabilities Research Reviews 8(1),
2002, pp. 51-57.
BRYSON, S. “Brief report: epidemiology of autism”. Journal of Autism and
Developmental Disorders 26, 1996, pp. 165-167.
BUCHSBAUM, M. S.; HOLLANDER, E.; HAZNEDAR, M. M.; TANG, C.;
SPEIGEL-COHEN, J.; WEI, T. C.; SOLIMANDO, A.; BUCHSBAUM, B. R.;
ROBINS, D.; BIENSTOCK, C.; CARTWRIGHT, C. e MOSOVICH, S.
“Effect of fluoxetine on regional cerebral metabolism in autistic spectrum
disorders: a pilot study”. International Journal of Neuropsychopharmacology
4, 2001, pp. 119-125.
BUITELAAR, J.; VAN DER GAAG, R.; KLIN, A. e VOLKMAN, F.
“Exploring the boundaries of pervasive developmental disorder not
otherwise specified: analyses of data from the DSM-IV autistic disorder
field trial”. Journal of Autism and Developmental Disorders 29, 1999, pp.
33-43.
BUXBAUM, J. D.; SILVERMAN, J. M.; SMITH, C. J.; GREENBERG, D.
A.; KILIFARSKI, M.; REICHERT, J.; COOK, E. H.; FANG, Y.; SONG, C. Y.
e VITALE, R. “Association between a GABRB3 polymorphism and autism”.
Molecular Psychiatry 7, 2002, pp. 311-316.
CARLSON, J. K., HAGIWARA, T. e QUINN, C. “Assessment of students
with autism”. In: R. L. Simpson e B. S. Myles (eds.). Educating children and
youth with autism. Austin: Pro-Ed, 1998, pp. 25-53.

